secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
CIK:        0001100682
Form:       8-K
Filed at:   2022-03-28T23:59:59+00:00
Accession:  0001100682-22-000010
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Charles River Labs appoints Flavia Pease as CFO; David Smith retires to Senior Advisor
--------------------------------------------------------------------------------

- Flavia Pease named Corporate EVP and CFO effective after Q1 2022 10-Q filing (~early May 2022).
- Pease joins from J&J, where she was VP and Group CFO of global Medical Devices ($27B revenue).
- Outgoing CFO David Smith will become Senior Financial Advisor until February 2023.
- Pease receives $600K base salary, 70% target bonus, $2M equity award, plus $1.7M new-hire equity.
- One-time signing bonus of $800,000, with $200K within 30 days and $600K after 12 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1100682/000110068222000010/0001100682-22-000010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1100682/000110068222000010/crl-20220328.htm
  HTML page:      https://secwatch.observer/filing/0001100682-22-000010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer